KAPOSI´S SARCOMA - A CLINICOPATHOLOGICAL REVIEW
Abstract
Introduction: Kaposi's sarcoma (KS) is a systemic disease, whose neoplastic or reactive nature is controversial and its etiologic agent is human herpes virus type 8 (HHV-8). There are 4 clinical subtypes: classical, epidemic, endemic and iatrogenic.
Material and methods: A retrospective review of clinical records and histological preparations of KS cases, diagnosed between January 2001 and December 2013 at the Dermatopathology Department of Hospital Egas Moniz and Centro de Dermatologia Médico-Cirúrgica de Lisboa was made and we assessed differences between the various types.
Results: Ninety-one cases were diagnosed, 67.0% of classic KS, 30.8% of epidemic KS; 1.1% of endemic KS and 1.1% of iatrogenic KS. It was found that 85.7% of patients were male and 14.3% were female, and this dominance occurred in all variants. The average age of patients with epidemic KS was lower than the classic variant (37.3 vs 70.0 years, p< 0.001). The lower limbs were the preferred location for all variants (74.2%). Histologically, in patients with classic KS, there was a predominance of the nodule stage (62.3%), while in epidemic KS, plaque was the most common stage (46.4 %) and this difference being almost statistically significant ( p = 0.057). No differences were observed in the various histological stages between classic and epidemic SK.
Conclusions: The observed differences in epidemic KS seem to relate more with subtle changes inherent to early lesions rather than only differences of this variant , which is in agreement with the literature.
Downloads
References
Schwartz RA, Micali G, Nasca MR, Scuderi L.Kaposi Sarcoma: A continuing conundrum. J Am Acad
Dermatol. 2008;59(2):179-206.
Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013; 137(2):289-94.
Esteves TC, Moura C, Rafael M, Sachse MF, Rosa JC, Rafael A, et al. Estudo epidemiológico dos doentes
com Sarcoma de Kaposi. Trab Soc Port Dermatol Venereol 2010; 68 (3): 373-9.
Dittmer DP, Damania B. Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)-an update. Curr
Opin Virol. 2013; 3(3):238-44.
Satter EK. Kaposi sarcoma. Cutis. 2013;91(3):120, 123-4.
Chor PJ, Santa Cruz DJ. Kaposi's sarcoma. A clinicopathologic review and differential diagnosis. J
Cutan Pathol. 1992; 19(1):6-20.
Daly, ML, Fogo A, McDonald C, Morris-Jones R. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm3 at presentation. Clin Exp Dermatol. 2014; 39: 7-12.
Calonje E, Brenn T, Lazar A, Mckee P. Kaposi´s sarcoma. In: Calonje E, Brenn T, Lazar A, Mckee P,
editors: Mckee´s Pathology of the Skin with clinical correlations. Amsterdam: Elsevier Saunders; 2012.
p.1729-1734.
O´Donell PJ, Pantanowitz L, Grayson W. Unique histologic variants of cutaneous Kaposi sarcoma. Am J Dermatopathol. 2010; 32(3): 244-50.
Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol. 2008;
;3:31.
All articles in this journal are Open Access under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).